Madrigal Pharmaceuticals is a biopharmaceutical company focused on innovative treatments for metabolic dysfunction-associated steatohepatitis (MASH).
Key features:
FDA-approved treatment for MASHFocus on halting or reversing liver scarringLeading clinical development program in MASHResearch on additional populations with high unmet needInnovative therapeutic approach using THR-β agonism
Pfizer is a leading biopharmaceutical company dedicated to discovering and developing innovative medicines and vaccines.
Key features:
Innovative cancer treatmentsComprehensive vaccine developmentPatient assistance programsResearch and development in chronic diseasesGlobal health initiatives
Comanche Biopharma is dedicated to making pregnancies safer through innovative therapies.
Key features:
Development of investigational siRNA medicineFocus on preterm preeclampsiaCommitment to evidence-based therapiesAccessibility for all women and babiesSupport resources for patients and survivors
A clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders.
Key features:
Genetics-based therapeutic targetsPatient-guided development strategiesEfficient clinical development pathsTranslational tools for validationFocus on neuronal excitation-inhibition balance
A biopharmaceutical company focused on developing next-generation therapies for patients with limited treatment options.
Key features:
Development of next-generation therapiesFocus on oncology and complex health conditionsCommitment to ethical standardsPatient-first approachCollaboration and impact-driven culture
Dren Bio is a clinical-stage biopharmaceutical company focused on developing novel antibody therapeutics.
Key features:
Novel antibody therapeuticsSelective depletion of pathogenic cellsClinical stage programs for oncologyClinical stage programs for autoimmune diseasesProprietary therapeutic development platform
Be Biopharma is dedicated to pioneering engineered B cell medicines for serious diseases.
Key features:
Patient-centered approachInnovative B cell therapiesFocus on serious diseasesIn vivo biologics developmentResearch and clinical trials
Sparrow Pharmaceuticals is focused on developing targeted therapies for type 2 diabetes.
Key features:
Targeted therapy for cardiometabolic diseaseHSD-1 inhibition to reduce cortisol levelsOnce-daily oral administrationFocus on treatment-resistant type 2 diabetesClinical-stage development
A biopharmaceutical company focused on developing innovative therapies for liver and viral diseases.
Key features:
Targeted therapies for liver diseasesInnovative treatments for viral infectionsStrong scientific foundation in medicinal chemistryPatient-centric drug developmentPipeline of best-in-class therapies
Savara Inc. is a clinical-stage biopharmaceutical company focused on rare respiratory diseases.
Key features:
Inhaled recombinant GM-CSFPhase 3 clinical developmentFocus on rare respiratory diseases
Aclaris Therapeutics is a biopharmaceutical company focused on innovative treatments for immuno-inflammatory conditions.
Key features:
Kinase inhibition for drug developmentNovel small and large molecule drugsMonoclonal and bispecific antibody developmentInnovative biologic therapiesFull-service drug discovery and early development
A biopharmaceutical company focused on drug discovery and development for autoimmune and inflammatory diseases.
Key features:
Scalable drug discovery modelDiversified portfolio of programsFocus on patient outcomesCommitment to scientific excellenceStrong leadership team with industry experience
A biopharmaceutical company dedicated to transforming innovation into value through new classes of medicine.
Key features:
Enhanced on-target efficacyOral administration capabilitiesImproved tolerabilityStrong clinical trial successRegulatory approval support
A clinical-stage biopharmaceutical company focused on developing innovative oral therapies for autoimmune, inflammatory, and neurodegenerative diseases.
Key features:
Development of small molecule therapeuticsExpertise in medicinal chemistryFocus on clinical trialsNLRP3 pathway modulationTherapies for high unmet medical needs
A clinical-stage biopharmaceutical company focused on precision small molecule medicines for CNS disorders.
Key features:
Precision targeting of neuronal receptor complexesMinimization of side effectsDevelopment of small molecule medicinesFocus on CNS disordersUtilization of RAP technology platform